BRONCHIOLITIS OBLITERANS SYNDROME
Clinical trials for BRONCHIOLITIS OBLITERANS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new BRONCHIOLITIS OBLITERANS SYNDROME trials appear
Sign up with your email to follow new studies for BRONCHIOLITIS OBLITERANS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung transplant drug trial halted early
Disease control TerminatedThis study tested a drug called itacitinib in 23 people who developed bronchiolitis obliterans syndrome (a type of lung scarring) after a double lung transplant. The goal was to see if the drug could improve lung function and was safe. The trial was stopped early, so results are …
Matched conditions: BRONCHIOLITIS OBLITERANS SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
Lung transplant drug trial halted: new inhaled therapy shows promise but study ends early
Disease control TerminatedThis study tested an inhaled form of cyclosporine A (L-CsA) plus standard care in 164 people who had a lung transplant and developed bronchiolitis obliterans, a condition that scars the small airways. The goal was to see if the treatment could slow lung function decline over 24 t…
Matched conditions: BRONCHIOLITIS OBLITERANS SYNDROME
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated May 11, 2026 20:40 UTC